Literature DB >> 26889479

Toward precision medicine in Parkinson's disease.

Lu-Lu Bu1, Ke Yang1, Wei-Xi Xiong1, Feng-Tao Liu1, Boyd Anderson1, Ye Wang1, Jian Wang1.   

Abstract

Precision medicine refers to an innovative approach selected for disease prevention and health promotion according to the individual characteristics of each patient. The goal of precision medicine is to formulate prevention and treatment strategies based on each individual with novel physiological and pathological insights into a certain disease. A multidimensional data-driven approach is about to upgrade "precision medicine" to a higher level of greater individualization in healthcare, a shift towards the treatment of individual patients rather than treating a certain disease including Parkinson's disease (PD). As one of the most common neurodegenerative diseases, PD is a lifelong chronic disease with clinical and pathophysiologic complexity, currently it is treatable but neither preventable nor curable. At its advanced stage, PD is associated with devastating chronic complications including both motor dysfunction and non-motor symptoms which impose an immense burden on the life quality of patients. Advances in computational approaches provide opportunity to establish the patient's personalized disease data at the multidimensional levels, which finally meeting the need for the current concept of precision medicine via achieving the minimal side effects and maximal benefits individually. Hence, in this review, we focus on highlighting the perspectives of precision medicine in PD based on multi-dimensional information about OMICS, molecular imaging, deep brain stimulation (DBS) and wearable sensors. Precision medicine in PD is expected to integrate the best evidence-based knowledge to individualize optimal management in future health care for those with PD.

Entities:  

Keywords:  OMICS; Parkinson’s disease (PD); Precision medicine; deep brain stimulation (DBS); molecular imaging; wearable sensors

Year:  2016        PMID: 26889479      PMCID: PMC4731609          DOI: 10.3978/j.issn.2305-5839.2016.01.21

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  79 in total

1.  Closed-loop deep brain stimulation is superior in ameliorating parkinsonism.

Authors:  Boris Rosin; Maya Slovik; Rea Mitelman; Michal Rivlin-Etzion; Suzanne N Haber; Zvi Israel; Eilon Vaadia; Hagai Bergman
Journal:  Neuron       Date:  2011-10-20       Impact factor: 17.173

Review 2.  Gut/brain axis and the microbiota.

Authors:  Emeran A Mayer; Kirsten Tillisch; Arpana Gupta
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

3.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

4.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

5.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

6.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

7.  Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Thomas O Mera; Michelle A Burack; Joseph P Giuffrida
Journal:  J Parkinsons Dis       Date:  2013-01-01       Impact factor: 5.568

8.  Caudo-rostral brain spreading of α-synuclein through vagal connections.

Authors:  Ayse Ulusoy; Raffaella Rusconi; Blanca I Pérez-Revuelta; Ruth E Musgrove; Michael Helwig; Bettina Winzen-Reichert; Donato A Di Monte
Journal:  EMBO Mol Med       Date:  2013-05-23       Impact factor: 12.137

9.  Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.

Authors:  Christopher B Forsyth; Kathleen M Shannon; Jeffrey H Kordower; Robin M Voigt; Maliha Shaikh; Jean A Jaglin; Jacob D Estes; Hemraj B Dodiya; Ali Keshavarzian
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

Review 10.  Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.

Authors:  Sylvia M Dobbs; R John Dobbs; Clive Weller; André Charlett; Aisha Augustin; David Taylor; Mohammad A A Ibrahim; Ingvar Bjarnason
Journal:  J Neurovirol       Date:  2015-06-20       Impact factor: 2.643

View more
  7 in total

Review 1.  Toward precision medicine in neurological diseases.

Authors:  Lin Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2016-03

Review 2.  MicroRNAs in Parkinson's disease and emerging therapeutic targets.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

3.  Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.

Authors:  Anna S Monzel; Lisa M Smits; Kathrin Hemmer; Siham Hachi; Edinson Lucumi Moreno; Thea van Wuellen; Javier Jarazo; Jonas Walter; Inga Brüggemann; Ibrahim Boussaad; Emanuel Berger; Ronan M T Fleming; Silvia Bolognin; Jens C Schwamborn
Journal:  Stem Cell Reports       Date:  2017-04-13       Impact factor: 7.765

4.  Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.

Authors:  Shumei Zhang; Yihan Wang; Yue Gu; Jiang Zhu; Ce Ci; Zhongfu Guo; Chuangeng Chen; Yanjun Wei; Wenhua Lv; Hongbo Liu; Dongwei Zhang; Yan Zhang
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

5.  Quadruple Decision Making for Parkinson's Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine.

Authors:  Lieneke van den Heuvel; Ray R Dorsey; Barbara Prainsack; Bart Post; Anne M Stiggelbout; Marjan J Meinders; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 6.  The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology.

Authors:  Mark Gray; James Meehan; Arran K Turnbull; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; David J Argyle
Journal:  Front Vet Sci       Date:  2020-11-12

Review 7.  From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis.

Authors:  Giovanna Morello; Salvatore Salomone; Velia D'Agata; Francesca Luisa Conforti; Sebastiano Cavallaro
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.